Interstitial Lung Disease News and Research

RSS
Interstitial lung disease (ILD) is a broad group of lung diseases comprising of more than a hundred distinct disorders. All of these involve scarring or inflammation of the interstitial lung tissue and affect the volume of oxygen that can reach the bloodstream via the respiratory system.
People with type 2 diabetes more likely to suffer from breathlessness, restrictive lung disease

People with type 2 diabetes more likely to suffer from breathlessness, restrictive lung disease

Low blood levels of vitamin D linked to increased risk of interstitial lung disease

Low blood levels of vitamin D linked to increased risk of interstitial lung disease

Chinese researchers report first clinical trial based on autologous lung stem cell transplantation

Chinese researchers report first clinical trial based on autologous lung stem cell transplantation

Exoskeleton device helps man with disabling condition to complete 10K race

Exoskeleton device helps man with disabling condition to complete 10K race

Researchers develop potential stem cell treatment for several lung conditions

Researchers develop potential stem cell treatment for several lung conditions

New survey reveals emotional, practical challenges facing people with idiopathic pulmonary fibrosis

New survey reveals emotional, practical challenges facing people with idiopathic pulmonary fibrosis

Statin medications can cause necrotizing myopathy in some patients

Statin medications can cause necrotizing myopathy in some patients

Novartis, Bristol-Myers Squibb collaborate to examine combination therapies for metastatic colorectal cancer

Novartis, Bristol-Myers Squibb collaborate to examine combination therapies for metastatic colorectal cancer

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda announces accelerated approval from FDA for new lung cancer treatment

Two thirds of IPF patients report being involved during the decision-making process for the most appropriate treatment

Two thirds of IPF patients report being involved during the decision-making process for the most appropriate treatment

Increasing idiopathic pulmonary fibrosis research

Increasing idiopathic pulmonary fibrosis research

Researchers crack genetic code of lung tissues to identify novel targets for treating IPF

Researchers crack genetic code of lung tissues to identify novel targets for treating IPF

FDG PET-CT imaging helps assess anatomical structure and metabolic activity in patients with GLILD

FDG PET-CT imaging helps assess anatomical structure and metabolic activity in patients with GLILD

Boehringer Ingelheim and Duke expand collaboration to create largest patient registry for idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim and Duke expand collaboration to create largest patient registry for idiopathic pulmonary fibrosis (IPF)

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

Pulmonary hypertension impacts walking ability in SSc patients

Pulmonary hypertension impacts walking ability in SSc patients

M10 peptide could help protect systemic sclerosis patients against fibrotic damage

M10 peptide could help protect systemic sclerosis patients against fibrotic damage

AstraZeneca reports new Phase I extended follow-up data on osimertinib in NSCLC patients at ELCC 2016

AstraZeneca reports new Phase I extended follow-up data on osimertinib in NSCLC patients at ELCC 2016

Understanding idiopathic pulmonary fibrosis: an interview with Michael Durheim, M.D.

Understanding idiopathic pulmonary fibrosis: an interview with Michael Durheim, M.D.